Indian healthcare industry has made a mark at the global level because of high quality of diverse clinical expertise and low costs of treatment. The country has a vast pool of clinicians, many of whom are trained in some of the advanced healthcare markets such as US and Europe and bring the best clinical practices on the table. The country has the largest pool of doctors and paramedics in South Asia (1.2 million Allopathic doctors. 0.17 million dental surgeons and about 2 million nurses). We also have a total of 24 JCI accredited and more than 350 NABH accredited hospitals in the country, something that gives us an edge in providing high quality clinical work at affordable prices.

The top global medical tourism destinations include Costa Rica, India, Israel, Malaysia, Mexico, Singapore, South Korea, Taiwan, Thailand, Turkey and the United States. Close to 600,000 medical tourists travelled to India in 2015. Indian healthcare industry today caters to about 1.25 billion Indians and people coming from Africa, Middle-East and SAARC countries. We cater to the healthcare needs of a population of almost 2 billion people globally. We get high value patients for surgeries in key specialties such as organ transplants (liver, heart & lung and kidney), neurosurgeries, cardiothoracic surgeries, oncology, orthopedics and many others.

Lately there is a steady stream of patients coming from former CIS countries, Russia and now even from US and some of the European countries. Indian healthcare organizations are also looking aggressively at some of the APAC countries such as Indonesia, Malaysia, Burma, Laos, Vietnam, as also at other far flung countries such as Mongolia.

Depreciation of Rupee: Depreciation of Rupee against dollar and other major Western currencies has been a boon to medical tourism and has made the costs of treatment far cheaper. This trend is likely to continue as India heads towards full convertibility in future. Medical Tourism Market Report: 2015 found that India was "one of the lowest cost and highest quality of all medical tourism destinations”. It offers a wide variety of procedures at about one-tenth the cost of similar procedures in the United States. Indian cost advantage accompanied by compatible quality speaks for itself. Various estimates put the treatment costs in India at around one-fifth to one-tenth of the price of comparable treatment costs in the US or the UK. Using US costs as a benchmark across a variety of specialties and procedures, average range of savings for the most-travelled destinations, a patient travelling to India can save anything up to 65-90%. The figure is 25-40% for Singapore, 50-75% for Thailand, 65-80% for Malaysia, 20-30% for Brazil, 30-45% for South Korea and 50-65% for Turkey.

Accreditations: Accreditations spell standardization and international quality, something that inspires confidence in inbound patients. We have JCI accredited hospitals similarly, the number of NABH accredited hospitals needs to go up if we have to build a comprehensive medical tourism ecosystem.
Test Data